Qiagen NV (NYSE:QGEN)
| 34.96 Delayed Data As of Jan 24 |  +0.14 / +0.40%Today’s Change | 25.04 Today|||52-Week Range 43.16 | +3.43% Year-to-Date |
Latest QGEN News | Press Releases
| Better Buy: Exact Sciences vs. Qiagen Jan 23 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 34.82 |
| Today’s open | 34.95 |
| Day’s range | 34.66 - 35.23 |
| Volume | 1,244,836 |
| Average volume (3 months) | 2,652,587 |
| Market cap | $8.1B |
Data as of 6:30pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | +366.67% |
| Earnings growth (this year) | +3.71% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +5.95% |
| P/E ratio | NM |
| Price/Sales | 5.36 |
| Price/Book | 2.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BRKRBruker Corp | -0.42 | -0.80% |
| BIOBio Rad Laboratories... | -5.37 | -1.43% |
| PKIPerkinElmer Inc | +0.39 | +0.39% |
| DHRPRADanaher Corp | +2.22 | +0.18% |
Data as of 6:30pm ET, 01/24/2020
Financials
| Next reporting date | February 5, 2020 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | $190.4M |
| Net profit margin | 12.68% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Venlo, Limburg |
Forecasts
